Fundraising Fox
🦊/Companies
Sign in

GreenMark Biomedical

East Lansing, US · Founded 2016 · Delaware corporation · 3 known investors

Find your way into GreenMark Biomedical

GreenMark develops non-invasive dental products for dentists, hygienists, and patients that treat tooth sensitivity and support oral health management. Its offerings include a mineral-depositing dental strip for sensitivity relief and a fluorescent rinse for early caries detection.

BiotechHealthtechMedical Devices

Founders & leadership

GreenMark Biomedical was founded in 2016 by Steven Bloembergen, PhD.

SBSteven Bloembergen, PhD
Steven Bloembergen, PhDFounder
SB
Steven BloembergenNamed on SEC filing

Board

MS
Michael SnyderBoard director
JL
Joerg Lahann, Ph.D.Board director
KP
Kenneth PientaBoard director
FV
Frank van LuttikhuizenBoard director

Investors · 3

ID VenturesDetroit · $50K – $250K
Invest MichiganNorthville · $100K – $250K
Michigan RiseEast Lansing · $50K – $150K

Reported raises · per SEC filings

Form D private placements

$1.7M disclosed across 2 of 5 rounds · 2018–2026

▶$5MofferedApr 2026 · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Steven Bloembergen PhDExecutive Officer, Director
  • Michael SnyderDirector
  • Joerg Lahann, PhDDirector
Offering amount
$5M
Minimum investment
$25K
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$500KofferedJan 2025 · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael SnyderDirector
  • Steven Bloembergen, PhDExecutive Officer, Director
  • Joerg Lahann, Ph.D.Director
Offering amount
$500K
Minimum investment
$10K
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$500KraisedOct 2022 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Joerg Lahann, Ph.D.Director
  • Jeff WesleyDirector
  • Frank van LuttikhuizenDirector
  • Steven BloembergenExecutive Officer, Director
  • Michael SnyderDirector
Offering amount
$1M
Amount sold
$500K
Minimum investment
$30K
First sale
Oct 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2MofferedJul 2020 · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael SnyderDirector
  • Joerg LaHann, Ph.D.Director
  • Steven BloembergenExecutive Officer, Director
  • Kenneth PientaDirector
  • Frank van LuttikhuizenDirector
Offering amount
$2M
Minimum investment
$25K
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.2MraisedMar 2019 · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Frank van Luttikhuizen, CPADirector
  • Joerg LaHann, Ph.D.Director
  • Michael D. SnyderDirector
  • Kenneth Pienta, M.D.Director
  • Steven Bloembergen, Ph.D.Executive Officer, Director
Offering amount
$1.2M
Amount sold
$1.2M
Minimum investment
$25K
First sale
May 2018
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap
Daymark Health4 shared keywordsDaymark provides 24/7 in-home and virtual cancer care, offering patients an oncology-specialized team available by phone, text, video, or home visits to coordinate testing, manage symptoms and medications, and handle care logistics. It works through patients' health insurance and partners with insurance providers, serving cancer patients, families, and their care teams.

Companies competing with GreenMark Biomedical for the same Google search keywords, organic and paid, via search-intersection analysis.

Non-dilutive funding · 2 SBIR/STTR awards

Federal grants — no equity taken
AgencyPhaseYearAmount
National Institutes of Health (NIH)National Institutes of HealthPhase II2019$1.5M
National Institutes of Health (NIH)National Institutes of HealthPhase I2018$228.9K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

In the news

GreenMark Biomedical Secures Follow-On Regenerative Medicine Grant Fundingeinpresswire.com · Aug 2026News & Events - GreenMark Biomedical Inc.greenmark.bio · Sep 2021GreenMark Biomedical's nanoparticle technology could change the game for tooth decay detection | Crain's Detroit Businesscrainsdetroit.com · Jun 2021GreenMark Secures Funding for Cavity Identification and Treatment Technologyprnewswire.com · Oct 2018

Frequently asked questions

What does GreenMark Biomedical do?
GreenMark develops non-invasive dental products for dentists, hygienists, and patients that treat tooth sensitivity and support oral health management. Its offerings include a mineral-depositing dental strip for sensitivity relief and a fluorescent rinse for early caries detection.
Who founded GreenMark Biomedical?
GreenMark Biomedical was founded by Steven Bloembergen, PhD in 2016.
Who are GreenMark Biomedical's investors?
GreenMark Biomedical's investors include ID Ventures, Invest Michigan, Michigan Rise.
How much funding has GreenMark Biomedical raised?
GreenMark Biomedical has disclosed $1.7M raised across 2 of its 5 known rounds.
Where is GreenMark Biomedical headquartered?
GreenMark Biomedical is headquartered in East Lansing, US.